We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
The US Supreme Court relaxed the deadlines for shareholder fraud actions, allowing investors to proceed with accusations that Merck & Co, the pharmaceutical company, misled the public about the health risks posed by its Vioxx painkiller, which was withdrawn because of links to heart attacks and strokes
